Caffeine

1. INCI et CAS

INCI: Caffeine · CAS: 58-08-2

2. Rôle dans la formule

Caffeine is used around 0.2–1% in cosmetic eye gels. This page does not claim a medical eye treatment.

3. Niveaux d'emploi typiques (repère de formulation)

• The level shown for eye gels and serums is 0.2–1% as a formulation guide.

Dissolve into water.

4. Sources réglementaires et conformité mondiale

• A CosIng entry naming Caffeine does not by itself approve the purchased grade or complete cosmetic.
• For an EU-market product, Regulation (EC) No 1223/2009 requires a safety assessment covering the complete formulation with Caffeine before the finished product is marketed.
• Match the selected Caffeine material to its supplier TDS and check the filing list for the market of sale.

5. Sécurité et évaluation des risques

The listed use rate is intended as a cosmetic-development guide; it should not be read as a drug authorization or OTC listing so assess patch response and stability in the final formula.

6. Stabilité et conditionnement

Hold the bulk material in a sealed, cool place shielded from light; for oxidation-sensitive formulas, consider an airless or pump pack; follow with stability and packaging checks on the confirmed batch.

7. Formulations d'allégations (à faire / à éviter)

• The cosmetic concept for Caffeine in this entry centers on caffeine eye-care.

• The ingredient record does not substantiate claims of drug action or cure, or a product certification outside the supporting records.
• This guide to Caffeine should not be cited in support of whitening, acne care as treatment, perspiration reduction, sun protection, or hair growth.

1. INCI et CAS

INCI: Glycerin · CAS: 56-81-5

2. Rôle dans la formule

For emulsions, gels, and washes, this guide assigns glycerin a polyol-humectant role. Its level is not a batch assay.

3. Niveaux d'emploi typiques (repère de formulation)

• Gels and serums: 3–8% for the formula.
• The creams use-level reference is 2–5% for the formula.
• The level shown for rinse-off is 2–4% for the formula.

Add Glycerin to the water phase; no separate melt step is needed.

4. Sources réglementaires et conformité mondiale

• CosIng provides reference information for Glycerin; confirm the specific grade and intended use against market requirements.
• An EU-market cosmetic under Regulation (EC) No 1223/2009 requires a safety assessment covering the complete formulation with Glycerin for the product in its final form.
• Use the supplier TDS to confirm grade-specific details for Glycerin and review the destination market's requirements.

5. Sécurité et évaluation des risques

The listed use rate is intended as a cosmetic-development guide; it does not establish drug approval or OTC-monograph status so the finished cosmetic should receive patch and stability checks.

6. Stabilité et conditionnement

Store sealed bulk away from heat and sunlight; if the formula is oxidation-sensitive, an airless or pump format may be considered; follow with stability and packaging checks on the confirmed batch.

7. Formulations d'allégations (à faire / à éviter)

• For cosmetic use, this entry records Glycerin in a direction centered on humectant function.

• The listed information cannot verify drug or therapeutic claims, clinical cures, or certification claims not confirmed for the product.
• This Glycerin listing does not confirm whitening, acne treatment, antiperspirant effects, sunscreen use, or hair growth.

1. INCI et CAS

INCI: Squalane · CAS: 111-01-3

2. Rôle dans la formule

The guide uses plant-derived squalane, a stable hydrocarbon emollient, and does not specify mineral oil.

3. Niveaux d'emploi typiques (repère de formulation)

• For gel-creams, the reference gives 2–6% as a formulation guide.
• Formulation guidance for dry oils: 10–30% in this reference.
• For balms, the recorded level is 5–15% as a formulation guide.

Use the oil phase to introduce Squalane; a high-shear wax stage is not specified.

4. Sources réglementaires et conformité mondiale

• If CosIng lists Squalane, that listing remains ingredient information; check rules for the intended market and use.
• For cosmetics placed on the EU market, Regulation (EC) No 1223/2009 requires an assessment of the safety of the final cosmetic containing Squalane before the finished product is marketed.
• Review the supplier TDS for the received Squalane grade, together with the target market's current filing requirements.

5. Sécurité et évaluation des risques

The concentration shown is guidance for cosmetic formulation; it does not establish drug approval or OTC-monograph status so patch response and stability should be checked on the finished product.

6. Stabilité et conditionnement

Keep the bulk container closed and shaded in a cool area; review airless or pump options if oxidation presents a concern; confirm final stability and pack compatibility on a representative batch.

7. Formulations d'allégations (à faire / à éviter)

• This guide frames Squalane's cosmetic direction around a light-emollient role.

• The ingredient record cannot substantiate drug claims, cure claims, or a certification that is absent from the product records.
• This guide to Squalane is not evidence for whitening, acne care as treatment, perspiration reduction, sun protection, or hair growth.